Zepbound beats Wegovy for weight loss
Digest more
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of safety, according to newly released comprehensive tolerability data—findings that Leerink analysts say confirm the GLP-1 drug’s edge in the closely watched market race.
1d
Best Life on MSNWeight-Loss Drugs Could Slash Cancer Risk by 41%—Here’s Who BenefitsParticipants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.
Hosted on MSN1d
Do Medicare, Medicaid cover weight loss drugs? It dependsWellcare, which offers Medicare Advantage and Medicare Prescription ... Because it is approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss. Patients paying the list price for the medication ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal regulators crack down on the
If a person has a Medicare Advantage ... cover Zepbound and other AOMs for treating obesity alone. The rules that govern Part D plans exclude “agents when used for weight loss.”